4.7 Review

Smart Nanotheranostics Responsive to Pathological Stimuli

Journal

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fbioe.2020.00503

Keywords

nanotheranostics; smart nanoparticles; pH-responsive theranostics; ROS-responsive theranostics; Enzyme-responsive theranostics

Funding

  1. Russian Science Foundation [16-15-10410]
  2. Russian Academic Excellence Project 5-100

Ask authors/readers for more resources

The development of nanotheranostics represents one of the most dynamic technological frontiers in the treatment of different pathological conditions. With the goal in mind to generate nanocarriers with both therapeutic and diagnostic properties, current research aims at implementing these technologies with multiple functions, including targeting, multimodal imaging, and synergistic therapies. The working mechanism of some nanotheranostics relies on physical, chemical, and biological triggers allowing for the activation of the therapeutic and/or the diagnostic properties only at the diseased site. In this review, we explored new advances in the development of smart nanotheranostics responsive to pathological stimuli, including altered pH, oxidative stress, enzymatic expression, and reactive biological molecules with a deep focus on the material used in the field to generate the particles in the context of the analyzed disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle-Mimetic Nanovesicles Loaded with Chemotherapeutics

Sergey Brezgin, Anastasiya Kostyusheva, Natalia Ponomareva, Ekaterina Bayurova, Alla Kondrashova, Anastasia Frolova, Olga Slatinskaya, Landysh Fatkhutdinova, Georgy Maksimov, Mikhail Zyuzin, Ilya Gordeychuk, Alexander Lukashev, Sergey Makarov, Alexander Ivanov, Andrey A. Zamyatnin Jr, Vladimir Chulanov, Alessandro Parodi, Dmitry Kostyushev

Summary: Biological nanoparticles, such as extracellular vesicles (EVs) and extracellular vesicle-mimetic nanovesicles (EMNVs), have been extensively studied as drug delivery vehicles in medical applications. This study investigated the properties and drug delivery abilities of EVs and EMNVs, and analyzed their use for delivering the chemotherapeutic drug doxorubicin. EMNVs were found to be more effectively internalized, while EVs showed higher intracellular release of doxorubicin.

PHARMACEUTICS (2023)

Review Biotechnology & Applied Microbiology

Technological aspects of manufacturing and analytical control of biological nanoparticles

Sergey Brezgin, Alessandro Parodi, Anastasiya Kostyusheva, Natalia Ponomareva, Alexander Lukashev, Darina Sokolova, Vadim S. Pokrovsky, Olga Slatinskaya, Georgy Maksimov, Andrey A. Zamyatnin Jr, Vladimir Chulanov, Dmitry Kostyushev

Summary: Extracellular vesicles (EVs), cell-derived biological nanoparticles, have gained significant interest for drug delivery due to their ideal biocompatibility, safety, ability to cross biological barriers, and surface modification potential. However, the translation of EVs into practical applications has been challenging due to issues in up-scaling, synthesis, and quality control methods. Advances in manufacturing technology now allow EVs to carry various therapeutic cargoes, and new technologies have been introduced to improve EV production, isolation, characterization, and standardization.

BIOTECHNOLOGY ADVANCES (2023)

Article Oncology

PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia

Mojdeh Soltani, Mustafa Ghanadian, Behrooz Ghezelbash, Abolfazl Shokouhi, Andrey A. A. Zamyatnin Jr, Alexandr V. V. Bazhin, Mazdak Ganjalikhani-Hakemi

Summary: Through this study, we found that PD-L1 stimulation can promote the proliferation and survival of AML stem cells, possibly through regulating the metabolic pathways of leukemic cells. PD-L1 stimulation affects glucose and fatty acid metabolism, increasing the expression of the pentose phosphate pathway and glycolysis in HL-60 and THP-1 cells, as well as increasing the expression of CPT1A while decreasing ACC1 expression.

BMC CANCER (2023)

Editorial Material Oncology

Current Perspectives in Ultra-sensitive Detection of Cancer-specific Biomarkers and Therapeutic Targets

Lyudmila V. Savvateeva, Evgeni Yu. Zernii, Andrey A. Zamyatnin

CURRENT CANCER DRUG TARGETS (2023)

Review Biochemistry & Molecular Biology

Bacterial Therapy of Cancer: A Way to the Dustbin of History or to the Medicine of the Future?

Larisa N. Ikryannikova, Neonila V. Gorokhovets, Darya A. Belykh, Leonid K. Kurbatov, Andrey A. Zamyatnin Jr

Summary: This article introduces the research on the relationship between bacteria and human tumors, including the efforts and achievements of ancient and modern scientists, as well as the challenges and achievements of 21st century science in using bacteria for cancer treatment. It also discusses the future possibilities of bacterial cancer therapy, including the creation of bacterial microrobots or bacteriobots.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G Expression

Ekaterina P. Kolesova, Vera S. Egorova, Anastasiia O. Syrocheva, Anastasiia S. Frolova, Dmitry Kostyushev, Anastasiia Kostyusheva, Sergey Brezgin, Daria B. Trushina, Landysh Fatkhutdinova, Mikhail Zyuzin, Polina A. Demina, Evgeny V. Khaydukov, Andrey A. Zamyatnin, Alessandro Parodi

Summary: Proteolytic activity plays a crucial role in cell homeostasis and function, with implications in cancer progression and treatment response. Endosomes, which are often the final destination of internalized nanoparticles, are major sites of cellular proteolytic activity. However, little is known about the impact of nanoparticles on endosomal biology. In this study, we generated albumin nanoparticles with varying resistance to proteolysis and demonstrated a relationship between their sensitivity to proteases and drug delivery properties, irrespective of the degree of proteolytic degradation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, Research & Experimental

Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus

Dmitry Kostyushev, Sergey Brezgin, Anastasiya Kostyusheva, Natalia Ponomareva, Ekaterina Bayurova, Natalia Zakirova, Alla Kondrashova, Irina Goptar, Anastasiya Nikiforova, Anna Sudina, Yurii Babin, Ilya Gordeychuk, Alexander Lukashev, Andrey A. Zamyatnin Jr, Alexander Ivanov, Vladimir Chulanov

Summary: APOBEC/AID cytidine deaminases play an important role in innate immunity and antiviral defenses. Researchers developed a CRISPR-activation-based approach to induce APOBEC/AID overexpression and control its effects on HBV replication and cellular toxicity. The study highlights the potential for precise control of APOBEC/AID activation as a strategy for suppressing HBV replication without toxicity.

MOLECULAR THERAPY-NUCLEIC ACIDS (2023)

Review Biochemistry & Molecular Biology

The emerging roles of long noncoding RNAs in lymphatic vascular development and disease

Konstantin I. Ivanov, Olga V. Samuilova, Andrey A. Zamyatnin Jr

Summary: Recent advancements in RNA sequencing technology have allowed for the exploration of the complex and versatile world of long noncoding RNAs (lncRNAs) in the human genome. Once thought to be transcriptional noise, lncRNAs are now recognized as essential regulators of gene expression networks that control development, homeostasis, and disease progression. The regulatory functions of lncRNAs are diverse, acting at various levels within the cell, and there is growing evidence for their involvement in lymphatic vascular development and disease.

CELLULAR AND MOLECULAR LIFE SCIENCES (2023)

Review Biochemistry & Molecular Biology

Signaling and Resistosome Formation in Plant Innate Immunity to Viruses: Is There a Common Mechanism of Antiviral Resistance Conserved across Kingdoms?

Peter A. Ivanov, Tatiana V. Gasanova, Maria N. Repina, Andrey A. Zamyatnin Jr

Summary: Virus-specific proteins can trigger hypersensitive response (HR) in plants, which is a type of cell death. The main cell death signaling pathway involves the interaction between HR-inducing proteins and nucleotide-binding leucine-rich repeats (NLR) proteins encoded by plant resistance genes. NLR proteins can act as both sensors and helpers, or form an activation network leading to oligomerization and formation of membrane-associated resistosomes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Editorial Material Immunology

Editorial: Cancer cell-intrinsic and -extrinsic factors affecting tumor immune evasion

Jiazheng Sun, Andrey A. Zamyatnin, Xiangliang Yuan, Yi Xiao, Hongzhong Li

FRONTIERS IN IMMUNOLOGY (2023)

Review Pharmacology & Pharmacy

Smart Delivery Systems Responsive to Cathepsin B Activity for Cancer Treatment

Vera S. Egorova, Ekaterina P. Kolesova, Manu Lopus, Neng Yan, Alessandro Parodi, Andrey A. Zamyatnin

Summary: Cathepsin B is a lysosomal cysteine protease involved in various cellular processes and its overexpression and activity have been linked to pathological conditions such as cancer. Targeting cathepsin B activity has become a promising strategy for tumor-specific therapy and drug delivery. This review summarizes different technologies designed to improve cancer treatments by responsive to cathepsin B activity, which plays a key role in disease progression and treatment response.

PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

Design and synthesis of atorvastatin derivatives with enhanced water solubility, hepatoselectivity and stability

Svetlana Yu. Maklakova, Anton V. Lopukhov, Alexandr D. Khudyakov, Sergey V. Kovalev, Maria P. Mazhuga, Olga E. Chepikova, Andrey A. Zamyatnin Jr, Alexander G. Majouga, Natalia L. Klyachko, Elena K. Beloglazkina

Summary: This study reports the synthesis and evaluation of atorvastatin conjugates targeting the galactose-specific hepatic asialoglycoprotein receptor (ASGPR). The prepared conjugates showed increased water solubility and demonstrated potent binding to the ASGPR. The conjugates with an amide bond displayed optimal stability and effectively inhibited HMG-R activity. These findings suggest that these compounds have the potential to be developed as orally administered prodrugs of atorvastatin.

RSC MEDICINAL CHEMISTRY (2023)

No Data Available